Recognition of nectin-2 by the natural killer cell receptor T cell immunoglobulin and ITIM domain (TIGIT)

Journal of Biological Chemistry

Volumn 292, Issue 27, 2017, Pages 11413-11422

  Deuss, Felix A ^a   Gully, Benjamin S ^a   Rossjohn, Jamie ^a,b   Berry, Richard ^a  

^a MONASH UNIVERSITY   (Australia)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANES; CRYSTAL STRUCTURE; DISEASES; LIGANDS; T-CELLS;

ADHESION MOLECULES; AUTOIMMUNE DISEASE; INNATE IMMUNE RESPONSE; MALIGNANT TRANSFORMATIONS; MOLECULAR SURFACES; MUTUALLY EXCLUSIVE EVENTS; NATURAL KILLER CELLS; RECEPTOR INTERACTION;

CYTOLOGY;

NATURAL KILLER CELL RECEPTOR; NECTIN 2; NECTIN 5; T CELL IMMUNOGLOBULIN AND ITIM DOMAIN PROTEIN; UNCLASSIFIED DRUG; CELL ADHESION MOLECULE; IMMUNOGLOBULIN RECEPTOR; NECTINS; TIGIT PROTEIN, HUMAN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; MUTAGENESIS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PROTEIN QUATERNARY STRUCTURE; PROTEIN SECONDARY STRUCTURE; X RAY CRYSTALLOGRAPHY;

CELL ADHESION MOLECULES; CRYSTALLOGRAPHY, X-RAY; HUMANS; MUTAGENESIS; PROTEIN DOMAINS; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, SECONDARY; RECEPTORS, IMMUNOLOGIC;

EID: 85023630086     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M117.786483     Document Type: Article

References (38)

1. Saunders, P. M., Vivian, J. P., O’Connor, G. M., Sullivan, L. C., Pymm, P., Rossjohn, J., and Brooks, A. G. (2015) A bird’s eye view of NK cell receptor interactions with their MHC class I ligands. Immunol. Rev. 267, 148 –166
2. Berry, R., Rossjohn, J., and Brooks, A. G. (2014) The Ly49 natural killer cell receptors: a versatile tool for viral self-discrimination. Immunol. Cell Biol. 92, 214 –220
3. Brooks, A. G., Posch, P. E., Scorzelli, C. J., Borrego, F., and Coligan, J. E. (1997) NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185, 795– 800
4. Lazetic, S., Chang, C., Houchins, J. P., Lanier, L. L., and Phillips, J. H. (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157, 4741– 4745
5. Andrews, D. M., Sullivan, L. C., Baschuk, N., Chan, C. J., Berry, R., Cotterell, C. L., Lin, J., Halse, H., Watt, S. V., Poursine-Laurent, J., Wang, C. R., Scalzo, A. A., Yokoyama, W. M., Rossjohn, J., Brooks, A. G., and Smyth, M. J. (2012) Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat. Immunol. 13, 1171–1177
6. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., and Brooks, A. G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813– 818
7. Boyington, J. C., Brooks, A. G., and Sun, P. D. (2001) Structure of killer cell immunoglobulin-like receptors and their recognition of the class I MHC molecules. Immunol. Rev. 181, 66 –78
8. Sullivan, L. C., Berry, R., Sosnin, N., Widjaja, J. M., Deuss, F. A., Balaji, G. R., LaGruta, N. L., Mirams, M., Trapani, J. A., Rossjohn, J., Brooks, A. G., and Andrews, D. M. (2016) Recognition of the major histocompatibility complex (MHC) class Ib molecule H2-Q10 by the natural killer cell receptor Ly49C. J. Biol. Chem. 291, 18740 –18752
9. Vivian, J. P., Duncan, R. C., Berry, R., O’Connor, G. M., Reid, H. H., Beddoe, T., Gras, S., Saunders, P. M., Olshina, M. A., Widjaja, J. M., Harpur, C. M., Lin, J., Maloveste, S. M., Price, D. A., Lafont, B. A., et al. (2011) Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B. Nature 479, 401– 405
10. Kärre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675– 678
11. Chan, C. J., Martinet, L., Gilfillan, S., Souza-Fonseca-Guimaraes, F., Chow, M. T., Town, L., Ritchie, D. S., Colonna, M., Andrews, D. M., and Smyth, M. J. (2014) The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat. Immunol. 15, 431– 438
12. Gilfillan, S., Chan, C. J., Cella, M., Haynes, N. M., Rapaport, A. S., Boles, K. S., Andrews, D. M., Smyth, M. J., and Colonna, M. (2008) DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors. J. Exp. Med. 205, 2965–2973
13. Martinet, L., and Smyth, M. J. (2015) Balancing natural killer cell activation through paired receptors. Nat. Rev. Immunol. 15, 243–254
14. Stanietsky, N., Simic, H., Arapovic, J., Toporik, A., Levy, O., Novik, A., Levine, Z., Beiman, M., Dassa, L., Achdout, H., Stern-Ginossar, N., Tsukerman, P., Jonjic, S., and Mandelboim, O. (2009) The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 106, 17858 –17863
15. Stanietsky, N., Rovis, T. L., Glasner, A., Seidel, E., Tsukerman, P., Yamin, R., Enk, J., Jonjic, S., and Mandelboim, O. (2013) Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR. Eur. J. Immunol. 43, 2138–2150
16. Yu, X., Harden, K., Gonzalez, L. C., Francesco, M., Chiang, E., Irving, B., Tom, I., Ivelja, S., Refino, C. J., Clark, H., Eaton, D., and Grogan, J. L. (2009) The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat. Immunol. 10, 48 –57
17. Liu, S., Zhang, H., Li, M., Hu, D., Li, C., Ge, B., Jin, B., and Fan, Z. (2013) Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ. 20, 456 – 464
18. Hsu, J. L., van den Boomen, D. J., Tomasec, P., Weekes, M. P., Antrobus, R., Stanton, R. J., Ruckova, E., Sugrue, D., Wilkie, G. S., Davison, A. J., Wilkinson, G. W., and Lehner, P. J. (2015) Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog. 11, e1004811
19. Matusali, G., Potestà, M., Santoni, A., Cerboni, C., and Doria, M. (2012) The human immunodeficiency virus type 1 Nef and Vpu proteins down-regulate the natural killer cell-activating ligand PVR. J. Virol. 86, 4496–4504
20. Tomasec, P., Wang, E. C., Davison, A. J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B. P., Morris, R. J., Llewellyn-Lacey, S., Rickards, C., Nomoto, A., Sinzger, C., and Wilkinson, G. W. (2005) Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6, 181–188
21. Gromeier, M., Lachmann, S., Rosenfeld, M. R., Gutin, P. H., and Wimmer, E. (2000) Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc. Natl. Acad. Sci. U.S.A. 97, 6803– 6808
22. Masson, D., Jarry, A., Baury, B., Blanchardie, P., Laboisse, C., Lustenberger, P., and Denis, M. G. (2001) Overexpression of the CD155 gene in human colorectal carcinoma. Gut 49, 236 –240
23. Oshima, T., Sato, S., Kato, J., Ito, Y., Watanabe, T., Tsuji, I., Hori, A., Kurokawa, T., and Kokubo, T. (2013) Nectin-2 is a potential target for antibody therapy of breast and ovarian cancers. Mol. Cancer 12, 60
24. Sloan, K. E., Eustace, B. K., Stewart, J. K., Zehetmeier, C., Torella, C., Simeone, M., Roy, J. E., Unger, C., Louis, D. N., Ilag, L. L., and Jay, D. G. (2004) CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 4, 73
25. Long, E. O., Burshtyn, D. N., Clark, W. P., Peruzzi, M., Rajagopalan, S., Rojo, S., Wagtmann, N., and Winter, C. C. (1997) Killer cell inhibitory receptors: diversity, specificity, and function. Immunol. Rev. 155, 135–144
26. Harrison, O. J., Vendome, J., Brasch, J., Jin, X., Hong, S., Katsamba, P. S., Ahlsen, G., Troyanovsky, R. B., Troyanovsky, S. M., Honig, B., and Shapiro, L. (2012) Nectin ectodomain structures reveal a canonical adhesive interface. Nat. Struct. Mol. Biol. 19, 906 –915
27. Stengel, K. F., Harden-Bowles, K., Yu, X., Rouge, L., Yin, J., Comps-Agrar, L., Wiesmann, C., Bazan, J. F., Eaton, D. L., and Grogan, J. L. (2012) Structure of TIGIT immunoreceptor bound to poliovirus receptor reveals a cell-cell adhesion and signaling mechanism that requires cis-trans receptor clustering. Proc. Natl. Acad. Sci. U.S.A. 109, 5399 –5404
28. Dam, J., Guan, R., Natarajan, K., Dimasi, N., Chlewicki, L. K., Kranz, D. M., Schuck, P., Margulies, D. H., and Mariuzza, R. A. (2003) Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat. Immunol. 4, 1213–1222
29. Aguilar, O. A., Berry, R., Rahim, M. M., Reichel, J. J., Popović, B., Tanaka, M., Fu, Z., Balaji, G. R., Lau, T. N., Tu, M. M., Kirkham, C. L., Mahmoud, A. B., Mesci, A., Krmpotić, A., Allan, D. S., et al. (2017) A viral immunoevasin controls innate immunity by targeting the prototypical natural killer cell receptor family. Cell 169, 58 –71 e14
30. Bork, P., Holm, L., and Sander, C. (1994) The immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242, 309 –320
31. Liu, J., Qian, X., Chen, Z., Xu, X., Gao, F., Zhang, S., Zhang, R., Qi, J., Gao, G. F., and Yan, J. (2012) Crystal structure of cell adhesion molecule nectin-2/CD112 and its binding to immune receptor DNAM-1/CD226. J. Immunol. 188, 5511–5520
32. Petrie, E. J., Clements, C. S., Lin, J., Sullivan, L. C., Johnson, D., Huyton, T., Heroux, A., Hoare, H. L., Beddoe, T., Reid, H. H., Wilce, M. C., Brooks, A. G., and Rossjohn, J. (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J. Exp. Med. 205, 725–735
33. Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., Vitale, M., Moretta, L., Lopez, M., and Moretta, A. (2003) Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198, 557–567
34. Tahara-Hanaoka, S., Shibuya, K., Onoda, Y., Zhang, H., Yamazaki, S., Miyamoto, A., Honda, S., Lanier, L. L., and Shibuya, A. (2004) Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). Int. Immunol. 16, 533–538
35. Seth, S., Maier, M. K., Qiu, Q., Ravens, I., Kremmer, E., Förster, R., and Bernhardt, G. (2007) The murine pan T cell marker CD96 is an adhesion receptor for CD155 and nectin-1. Biochem. Biophys. Res. Commun. 364, 959 –965
36. Berry, R., Vivian, J. P., Deuss, F. A., Balaji, G. R., Saunders, P. M., Lin, J., Littler, D. R., Brooks, A. G., and Rossjohn, J. (2014) The structure of the cytomegalovirus-encoded m04 glycoprotein, a prototypical member of the m02 family of immunoevasins. J. Biol. Chem. 289, 23753–23763
37. Berry, R., Ng, N., Saunders, P. M., Vivian, J. P., Lin, J., Deuss, F. A., Corbett, A. J., Forbes, C. A., Widjaja, J. M., Sullivan, L. C., McAlister, A. D., Perugini, M. A., Call, M. J., Scalzo, A. A., Degli-Esposti, M. A., et al. (2013) Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat. Immunol. 14, 699 –705
38. Aricescu, A. R., Lu, W., and Jones, E. Y. (2006) A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D Biol. Crystallogr. 62, 1243–1250